338 related articles for article (PubMed ID: 25899758)
1. Pathways in the diagnosis and management of diabetic polyneuropathy.
Kaku M; Vinik A; Simpson DM
Curr Diab Rep; 2015 Jun; 15(6):609. PubMed ID: 25899758
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy.
Bönhof GJ; Herder C; Ziegler D
Curr Diabetes Rev; 2022; 18(5):e120421192781. PubMed ID: 33845748
[TBL] [Abstract][Full Text] [Related]
3. Whither pathogenetic treatments for diabetic polyneuropathy?
Boulton AJ; Kempler P; Ametov A; Ziegler D
Diabetes Metab Res Rev; 2013 Jul; 29(5):327-33. PubMed ID: 23381942
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic neuropathy: an update].
Andrade Lopes S; Fayolle D; Jornayvaz FR
Rev Med Suisse; 2022 Jun; 18(784):1106-1109. PubMed ID: 35647748
[TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
[TBL] [Abstract][Full Text] [Related]
6. Distal sensory polyneuropathy in the context of HIV/AIDS.
Nicholas PK; Mauceri L; Slate Ciampa A; Corless IB; Raymond N; Barry DJ; Viamonte Ros A
J Assoc Nurses AIDS Care; 2007; 18(4):32-40. PubMed ID: 17662922
[TBL] [Abstract][Full Text] [Related]
7. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
Ziegler D; Tesfaye S; Spallone V; Gurieva I; Al Kaabi J; Mankovsky B; Martinka E; Radulian G; Nguyen KT; Stirban AO; Tankova T; Varkonyi T; Freeman R; Kempler P; Boulton AJ
Diabetes Res Clin Pract; 2022 Apr; 186():109063. PubMed ID: 34547367
[TBL] [Abstract][Full Text] [Related]
8. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic polyneuropathy].
Ziegler D
Internist (Berl); 2020 Mar; 61(3):243-253. PubMed ID: 32086529
[TBL] [Abstract][Full Text] [Related]
10. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity.
Dyck PJ; Albers JW; Andersen H; Arezzo JC; Biessels GJ; Bril V; Feldman EL; Litchy WJ; O'Brien PC; Russell JW;
Diabetes Metab Res Rev; 2011 Oct; 27(7):620-8. PubMed ID: 21695763
[TBL] [Abstract][Full Text] [Related]
11. A brief overview of the diabetic neuropathies.
Boulton AJM
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110758. PubMed ID: 38245328
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the management of diabetic polyneuropathy.
Ziegler D
Curr Diabetes Rev; 2011 May; 7(3):208-20. PubMed ID: 21534920
[TBL] [Abstract][Full Text] [Related]
13. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
[TBL] [Abstract][Full Text] [Related]
14. Current concepts in the management of diabetic polyneuropathy.
Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
[TBL] [Abstract][Full Text] [Related]
15. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
[TBL] [Abstract][Full Text] [Related]
16. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN).
Sharma S; Rayman G
Front Endocrinol (Lausanne); 2023; 14():1165505. PubMed ID: 37274325
[TBL] [Abstract][Full Text] [Related]
17. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
18. Screening tests for distal symmetrical polyneuropathy in Latin American patients with type 2 diabetes mellitus.
Gómez-Banoy N; Cuevas V; Soler F; Pineda MF; Mockus I
Arch Endocrinol Metab; 2017; 61(5):470-475. PubMed ID: 28724059
[TBL] [Abstract][Full Text] [Related]
19. Diabetic Neuropathy.
Zakin E; Abrams R; Simpson DM
Semin Neurol; 2019 Oct; 39(5):560-569. PubMed ID: 31639839
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for diabetic polyneuropathy treatment.
Basić-Kes V; Zavoreo I; Rotim K; Bornstein N; Rundek T; Demarin V
Acta Clin Croat; 2011 Jun; 50(2):289-302. PubMed ID: 22263398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
